<code id='5942241377'></code><style id='5942241377'></style>
    • <acronym id='5942241377'></acronym>
      <center id='5942241377'><center id='5942241377'><tfoot id='5942241377'></tfoot></center><abbr id='5942241377'><dir id='5942241377'><tfoot id='5942241377'></tfoot><noframes id='5942241377'>

    • <optgroup id='5942241377'><strike id='5942241377'><sup id='5942241377'></sup></strike><code id='5942241377'></code></optgroup>
        1. <b id='5942241377'><label id='5942241377'><select id='5942241377'><dt id='5942241377'><span id='5942241377'></span></dt></select></label></b><u id='5942241377'></u>
          <i id='5942241377'><strike id='5942241377'><tt id='5942241377'><pre id='5942241377'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:83
          Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT
          Adobe

          LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

          Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

          advertisement

          “A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          App could help diagnose ear infections more accurately — and at home
          App could help diagnose ear infections more accurately — and at home

          AUWSchoolofMedicineprofessorpracticesusingtheappandfunneltocheckhisdaughter'sear.DennisWise/Universi

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Baby aspirin cuts fat buildup in liver disease patients, in small study

          PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis